Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis
Ryan Malcolm Hum(Manchester Royal Infirmary), Ann Brownfield, Ben Thompson(Manchester Royal Infirmary), Andrew Hassell(Keele University), Nicola Williams(University of Oxford), Bridget Griffiths(Freeman Hospital), Piers Dawes(The University of Queensland), T Price, Paul Peterson(Manchester Royal Infirmary), Louisa J Badcock, Randall M. Stevens, Ann W Morgan(University of Leeds), Séamus O’Reilly(Royal College of Surgeons in Ireland), Paul Emery(University of Leeds), Chris Deighton(Manchester Royal Infirmary), Anne Barton(University of Manchester), Wan‐Fai Ng(University College Cork), T. Ding, Meghna Jani(Manchester Academic Health Science Centre), V Chalam(University of Manchester), Helen Foster, Kimme L Hyrich(Manchester Royal Infirmary), Alice Lorenzi(Manchester Royal Infirmary), Sivasubramanian Baskar(Chapel Allerton Hospital), John D. Isaacs(Newcastle upon Tyne Hospitals NHS Foundation Trust), Philip Platt, M F Shadforth, Lesley Kay(Newcastle upon Tyne Hospitals NHS Foundation Trust), Jon Packham(University of Nottingham), Douglas G. Walker(Emory University), Anthony G. Wilson(University College Dublin), Pauline Ho(Manchester Royal Infirmary), Sanjeet Kamath, Gregory D. Summers, Marian Regan, Christopher G. Dowson(University of Warwick), Thomas Sheeran, Michael S. Lee, D. Mulherin, Mark Friswell(Great North Children's Hospital), Hill Gaston, I D Griffiths(Royal Victoria Infirmary), MH Buch, Sarah Bingham, Nisha Nair(University of Manchester), N. Raj(Manchester Royal Infirmary), Darren Plant(Manchester Royal Infirmary)
Cited by 8
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
|Nature Genetics|2010|1.1k
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988